tives was also obtained for a control series of women drawn from the same doctors' practices as those in which the fatalities occurred.
A strong relation was found between the use of oral contraceptives and death from pulmonary embolism or cerebral thrombosis in the absence of predisposing conditions. The mortality from these two diseases attributable to the use of oral contraceptives by healthy women was estimated at 1.3 per 100,000 users aged 20-34 and 3.4 per 100,000 users aged 35-44 per annum.
The women who died from coronary thrombosis in the absence of predisposing conditions had been using oral contraceptives more frequently than would have been expected from the experience of the control group, but the difference did not quite attain statistical significance, and the existence of a definite association is regarded as not proved. If it is considered justifiable to include deaths from coronary thrombosis in the above estimates of attributable mortality, they may be recalculated as 2.2 and 4.5 per 100,000 users per annum for women aged 20-34 and 35-44 respectively, figures which agree closely with the estimate of risk given by the Medical Research Council (1967) in its preliminary report. It is probable, however, that all these estimates of risk are too low because information from independent sources indicates that our control data substantially overestimated the use of oral contraceptives by the general population in 1966. No evidence was found that the risk of thromboembolism was associated with the use of any particular oral contraceptive formulation.
Only 15 % of the deaths of women who were found to have been using oral contraceptives were reported independently to the Committee on Safety of Drugs.
In May 1967 a subcommittee of the Medical Research Council reviewed the preliminary results of three inquiries into the risks of thromboembolic disease in women taking oral contraceptives. One study concerned episodes of thromboembolic disease seen in general practice, and the final results have been reported by the Royal College of General Practitioners (1967) . Another concerned women who died of thromboembolic disease in England, Wales, and Northern Ireland in 1966;  it was undertaken by the Committee on Safety of Drugs, the full results being reported elsewhere in this issue by Inman and Vessey (1968) . The third, which was carried out by the Medical Research Council's Statistical Research Unit, concerned women admitted to hospital for deep vein thrombosis and pulmonary embolism. We now report the final results of this study, based on more than double the number of patients, and add some new data on women with cerebral or coronary thrombosis.
I. Deep Vein Thrombosis and Pulmonary Embolism
Method Co-operation was sought and obtained from the medical staff of the 19 general hospitals of more than 300 beds situated in the catchment area of the North-West Metropolitan Regional Hospital Board, which maintained a sufficiently detailed nosological index. At each hospital the index was searched and the case notes were reviewed relating to all women who (1) had been admitted to hospital in 1964-6; (2) were aged 16 to 40 years inclusive; and (3) had been diagnosed as suffering from a condition coded Nos. 463-466 in the Inter.
national Classification of Diseases (World Health Organization, 1957) 1-that is, from phlebitis, thrombophlebitis, thrombosis, or embolism in any vein except the cerebral, coronary, hepatic, and mesenteric veins; pulmonary embolism or infarction.
Or the equivalent numbers at the four hospitals which used other coding systems.
All women who satisfied these criteria were included unless they: (1) were single or widowed; (2) had an evident predisposing reason for developing the disease-that is, were suffering from some other relevant acute. or chronic disease or had within the previous three months been pregnant, undergone a surgical operation, or suffered trauma requiring hospital treatment; (3) were pregnant, postmenopausal, or sterilized; (4) had suffered only superficial thrombophlebitis; or (5) could not be interviewed because they had died during their stay in hospital.
If there was a doubt about the eligibility of a patient for inclusion, an abstract of the case history was prepared, omitting reference to contraceptive habits, and the decision was made independently by a colleague (Dr. Frank Speizer).
For each affected patient two control patients were selected who had been diagnosed as suffering from an acute medical or surgical condition or had been admitted to hospital for an elective operation (other than on varicose veins), and who matched the affected patient in regard to hospital, date of admission (within four months), age (within four years), parity (within groups 0, 1-2, or 3 or more deliveries), and absence of any of the attributes used to exclude patients from the affected series.
Permission to interview the patients was obtained from hospital consultants and general practitioners; the patients were then interviewed in their homes by a medical social worker experienced in research (Miss Keena Jones). At this interview inquiries were made about the patient's medical, obstetric, social, family, and contraceptive history.
Efforts were made to trace all the patients, but no attempt was made to contact those who had left the United Kingdom and Ireland. When control patients were found to have emigrated others were substituted for them. A few patients who could not be interviewed personally were asked to complete a postal questionary instead.
Material
Altogether 399 patients were identified who had been treated for venous thrombosis or pulmonary embolism. Of these, 338 were excluded for the reasons given in Table I . The criteria for exclusion were applied in the order shown, so that if, for (97) 106 (100)_ l Total .. 5 (4) 111 (96) 116 (100) Comparison between frequency of previous attacks (all affected and control patients): x2 = 28-5, n = 1, P < 0-001.
Comparison between frequency of use of oral contraceptives (affected and control patients without previous attacks): X2 = 27 0, n = 1, P < 0-001.
One hundred and forty-eight patients had never had a previous attack of thromboembolism, and in these women also the use of oral contraceptives was significantly more frequent in the affected group patients and controls, the risk of thromboembolism is increased by previous attacks and by obesity (Coon and Coller, 1959b; Fleming and Bailey, 1966) and that the use of oral contraceptives tends to increase weight (World Health Organization, 1966) .
Bias in Diagnosis
An alternative explanation of the results is that a history of the use of oral contraceptives led to the recognition of thromboembolic disease which would otherwise have been missed. It is easy to overlook the diagnosis of both deep vein thrombosis and pulmonary embolism (Coon and Coller, 1959a; Medd and McBrien, 1962; Hamilton and Thompson, 1963; Richards, 1966) , and the reports of thrombosis in women who used oral contraceptives, which began to appear in British medical journals in 1961, will have alerted doctors to the possibility of its occurrence.
If this were the explanation, the strongest association should be found in those patients for whom the diagnosis was least evident, as this group would contain patients whose condition was diagnosed only because they were known to have been using oral contraceptives. We (Haeger, Nilsson, and Robertson, 1967 as sufficiently strong evidence to justify classing the diagnosis as at least " probable." Table IX shows that within each disease category the use of oral contraceptives was no greater, and was indeed less, when the diagnosis was less certain, and that the proportion of affected patients who had used oral contraceptives was higher among those who suffered from the serious condition of pulmonary embolism than among those who suffered deep vein thrombosis alone. It seems improbable, therefore, that the observed association is due to a greater tendency to diagnose thromboembolic disease in women who use oral contraceptives. Table X shows the number of affected women admitted to hospital each year. No trend with time is evident. The numbers each year are small and the changes, though not providing much positive evidence in support, are statistically compatible with the hypothesis that the incidence of thromboembolism is static in women not using oral contraceptives and is rising in step with the number at risk in women who are. It should be noted, however, that the incidence of thromboembolic disease may have been increasing before oral contraceptives were widely introduced (Morrell, Truelove, and Barr, 1963; Loehry, 1966) tives for less than six months, and the corresponding proportion for the control patients was almost identical (4 out of 10).
Distribution of Affected Patients by Calendar Year
Family History All affected and control patients were questioned about the illnesses and causes of death of their parents and sibs. No significant differences were found between the numbers of relatives who had died from a variety of causes. There were, however, small differences in the reported frequency of morbidity from phlebitis among both mothers and sisters. Thus nine mothers and seven sisters of the affected women and nine mothers and two sisters of twice as many control women were reported to have suffered from non-fatal phlebitis.
These differences may indicate family predilection for venous thromboembolism or they may be the result of preferential recall by the affected subjects. There was no suggestion that a positive family history might be more common among affected women who used oral contraceptives than among affected women who did not.
Estimate of Incidence
Data provided by the North-West Metropolitan Regional Hospital Board indicates that the hospitals participating in the study include approximately 60% of the Board's female acute general medical and surgical beds. All but one of the affected patients resided within the Board's catchment area at the time of admission to hospital, so that we can reasonably relate our findings to the population of that area.
The total number of woman-years at risk can be estimated by reducing the size of the total female population aged 16 Firstly, all notes were excluded relating to women who were single or widowed, postmenopausal, sterilized, pregnant, or puerperal, or had a predisposing condition adequate to account for the development of a cerebrovascular disturbance. Secondly, notes were excluded which related to episodes where there was proof that the diagnosis was one of haemorrhage or which were obviously not due to cerebral thrombosis. Abstracts of the remaining 16 sets of notes were then prepared and were reviewed by a neurologist (Dr. Gerald Stem) without knowledge of the patients' contraceptive practice. Nine patients were accepted as having had a cerebral thrombosis, but the diagnosis was regarded as certain (angiographic evidence of arterial occlusion at a site which could be related to the focal signs) in only two.
The nine patients were interviewed in their homes (five) or completed postal questionaries (four) in the same way as the patients suffering from venous thrombosis or pulmonary embolism. Five (including one in whom the diagnosis was certain) had been using oral contraceptives during the month before they became ill and for periods ranging from one week to four years previously.
For comparison we have used the control patients selected to match the women with venous thromboembolic disease. Of these, 10 out of 116 used oral contraceptives (see Table IV ), so that the crude number expected among the women with "cerebral thrombosis" would have been less than one (0.8).
If account is taken of the age, parity, and year of admission of the women with " cerebral thrombosis" the expected number (1.0) is hardly altered. Even with these few patients the difference between the observed and the expected numbers of women using oral contraceptives is statistically significant (P<0.01).
III. Coronary Thrombosis
It was again impracticable to review all the notes coded under International Classification of Disease rubric 420 (arteriosclerotic heart disease, including coronary disease) at three hospitals, because the diagnostic index was incomplete and our results relate only to patients treated at 16 hospitals during the period 1964-6.
All notes were excluded relating to women who were single or widowed, postmenopausal, sterilized, pregnant, or puerperal, or had a predisposing condition; the remainder were classified into three diagnostic groups-angina pectoris only, possible coronary thrombosis (only ST or T changes in the electrocardiogram, but showing progression; serum enzymes either not done or offering no support to the diagnosis), and certain coronary thrombosis (pathological Q waves in the electrocardiogram or only ST or T changes accompanied by supporting serum enzyme changes). None of the notes relating to patients in these categories made any mention of oral contraceptives; there was therefore no risk of bias, and the classification was made without reference to others.
Sixteen women were accepted as having had coronary thrombosis without predisposing cause. Three had died and were excluded from the study because they could not be interviewed ; of the remainder, the diagnosis was regarded as certain in four. All 13 patients were either interviewed (12) or had completed a postal questionary (1), and none had taken oral contraceptives during the month before the onset of their disease. The number expected to have done so, from the experience of the control subjects selected to match the patients with venous thromboembolic disease, was 0.7.' IV. Discussion
Pulmonary Embolism and Deep Vein Thrombosis
Retrospective studies of hospital patients are always open to bias, and the present study is no exception. Both the affected and the control patients were selected from larger groups by procedures that were certainly not random, and information about the use of oral contraceptives was obtained by inquiry of the patient and so was dependent on the accuracy of her memory. The evidence, however, suggests that these sources of bias have not materially affected the results.
Firstly, women were selected for inclusion only for objective reasons, and any subsequent decision to exclude them for subjective reasons-for example, the presence of doubtfully significant predisposing disease-was taken in ignorance of their contraceptive practice. Secondly, the proportion of women with deep vein thrombosis or pulmonary embolism who used oral contraceptives was greater when the diagnosis was firmly established than when the diagnosis was less certainand the contrary would be expected if diagnosis and referral to hospital were biased by knowledge of the women's contraceptive practice. Thirdly, the proportion of control women who said they were using oral contraceptives (9%) England, Wales, and Northern Ireland in 1966 (62%, Inman and Vessey, 1968) . We conclude, therefore, that the method of investigation has not materially biased the results and that the association between the use of oral contraceptives and the development of deep vein thrombosis or pulmonary embolism is real.
Two considerations suggest that the association reflects cause and effect. Firstly, we have been unable to find any evidence of a third factor which could account for the association by being related to both. Many factors which cause the disease or influence the use of contraceptives were excluded by the design of the study. Two-previous attacks of thromboembolism and obesity-were not excluded; both were found more commonly in affected patients, but neither was particularly associated with the use of oral contraceptives. Others were either unrelated to the disease or the relation was so weak that it could have had no material effect on the results. Secondly, there is evidence that oestrogens can cause thromboembolism in other circumstances (Daniel, Campbell, and Turnbull, 1967; Oliver, 1967; Bailar, 1967; Schrogie and Solomon, 1967) .
Further evidence should eventually be obtained from examining trends in the incidence of the condition and its geographical distribution, particularly as the use of oral contraceptives has become more common than it was in 1966. The results of our study are quantitatively similar to those obtained by the Royal College of General Practitioners (1967) and the Committee on Safety of Drugs (Inman and Vessey, 1968) .
In In the second study (Inman and Vessey, 1968) 
Cerebral and Coronary Thrombosis
Our data contribute little new information relating to the occurrence of cerebral and coronary thrombosis. Only nine previously healthy women who were married and aged 40 years or under were treated for "cerebral thrombosis" and 16 (including three who died) from coronary thrombosis in 16 large hospitals in a three-year period. The diagnosis of cerebra] thrombosis is difficult to establish with certainty, and it is possible that the majority of patients in our small series suffered from some other intracranial condition. It is notable, however, that five of the nine patients had been using oral contraceptives when their disease began. This finding in itself implies little, but taken in conjunction with the similar findings of the Committee on Safety of Drugs (Inman and Vessey, 1968) , of Bickerstaff and Holmes (1967) , and of Illis et al. (1965) , it justifies the conclusion that oral contraceptives can be a cause: (see Schrogie and Solomon, 1967) . The study of the Committee on Safety of Drugs (Inman and Vessey, 1968) is compatible with some increased risk under 35 years of age, but the 13 patients with non-fatal coronary thrombosis in our study (only five of whom were under 35 years of age) offer no further support. We conclude that the existence of a risk of coronary thrombosis is not proved. If, as our data suggest, women who use oral contraceptives are somewhat heavier smokers than average, this factor will need to be taken into account in interpreting future findings (Ddrken, 1967 At 16 hospitals women suffering from coronary or cerebral thrombosis were also studied. Five of nine patients who survived an attack of " cerebral thrombosis " had been using oral contraceptives during the month preceding their illness. Taken in conjunction with other similar findings, it is justifiable to conclude that oral contraceptives can also be a cause of cerebrovascular insufficiency.
Of the 13 women who survived an attack of coronary thrombosis without evident predisposing cause none had been using oral contraceptives.
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